Inhibition of LPS-induced neutrophil recruitment in the lungs correlates with modulation of neutrophil CD11b expression using the selective CXCR2 receptor antagonist SB-656933 Source: Eur Respir J 2004; 24: Suppl. 48, 218s Year: 2004
Employing flow cytometric assays of human whole blood neutrophil and monocyte CD11b upregulation and shape change to assess a chemokine receptor (CXCR2) antagonist Source: Annual Congress 2005 - Therapeutic options for COPD: present and future Year: 2005
TNF-α inhibits human eosinophil apoptosis by activating p55 receptor and NF-κB Source: Eur Respir J 2001; 18: Suppl. 33, 162s Year: 2001
A CXCR2 antagonist inhibits polyI:C-induced airway neutrophil, but not lymphocyte infiltrate Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011
Inhibition of eosinophil migration by montelukast, a cysteinyl leukotriene receptor antagonist, through down regulation of plasmin activity Source: Eur Respir J 2004; 24: Suppl. 48, 36s Year: 2004
Expression of the chemokine receptors CXCR1 and CXCR2 on bronchial epithelial cells Source: Eur Respir J 2004; 24: Suppl. 48, 551s Year: 2004
The pro-apoptotic effect of cysteinyl leukotriene receptor (CysLT-R) antagonist montelukast is mediated by CysLT-Rs expression on antigen-stimulated T cells Source: Eur Respir J 2003; 22: Suppl. 45, 100s Year: 2003
Stimulation of P2 purinergic receptors induces the release of eosinophil cationic protein and interleukin-8 from human eosinophils Source: Eur Respir J 2003; 22: Suppl. 45, 548s Year: 2003
Effects of CXCR2 antagonists on neutrophil chemotaxis from COPD patients Source: Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs Year: 2010
Eosinophil adhesion to cholinergic nerve cells induces NFκB activation via the interleukin-1 receptor associated kinase (IRAK) pathway and upregulates ICAM-1 expression Source: Eur Respir J 2003; 22: Suppl. 45, 10s Year: 2003
Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing VEGF expression Source: Eur Respir J 2004; 24: Suppl. 48, 129s Year: 2004
Pneumolysin mediates neutrophil:platelet aggregation via a P-selectin- and protease-activated receptor-1 (PAR-1)-dependent mechanism Source: International Congress 2017 – How can microbiology and translational research help physicians? Year: 2017
Platelet activating factor increases β2 -integrin mediated eosinophil adhesion to ICAM-1 through focal clustering of CD11b Source: Annual Congress 2004 - Genetics and molecular mechanisms of COPD and asthma Year: 2004
Leukotriene D4 activates beta2-integrin adhesion in human polymorphonuclear leukocytes Source: Eur Respir J 2010; 35: 402-409 Year: 2010
The up-regulation of cysteinyl-leukotriene receptors on T cells Source: Eur Respir J 2003; 22: Suppl. 45, 395s Year: 2003
Cloning and expression of a 5-oxo-ETE receptor highly expressed on human eosinophils and neutrophils Source: Eur Respir J 2003; 22: Suppl. 45, 106s Year: 2003
Serotonin (5-hydroxytryptamine) modulates cytokine and chemokine production in lipopolysaccharide-primed human monocytes via stimulation of different 5-HT receptor subtypes Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma Year: 2005
LSC 2011 Abstract: P2Y2 receptor regulates VCAM-1 membrane and soluble forms and eosinophil accumulation during lung inflammation Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011
Activation of PAR-2 enhances ICAM-1 expression and IL-8 release in airway epithelial cells Source: Eur Respir J 2002; 20: Suppl. 38, 571s Year: 2002
The human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors Source: Eur Respir J 2004; 24: Suppl. 48, 36s Year: 2004